CO4480099A1 - A PRE-CONCENTRATE OF MICROEMULSION THAT INCLUDES A HARDLY SOLUBLE ACTIVE AGENT AND A CARRIING MEDIA - Google Patents

A PRE-CONCENTRATE OF MICROEMULSION THAT INCLUDES A HARDLY SOLUBLE ACTIVE AGENT AND A CARRIING MEDIA

Info

Publication number
CO4480099A1
CO4480099A1 CO95050316A CO95050316A CO4480099A1 CO 4480099 A1 CO4480099 A1 CO 4480099A1 CO 95050316 A CO95050316 A CO 95050316A CO 95050316 A CO95050316 A CO 95050316A CO 4480099 A1 CO4480099 A1 CO 4480099A1
Authority
CO
Colombia
Prior art keywords
active agent
composition
carriing
microemulsion
concentrate
Prior art date
Application number
CO95050316A
Other languages
Spanish (es)
Inventor
Sylvain Cottens
Barbara Haeberlin
Richard Sedrani
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421613A external-priority patent/GB9421613D0/en
Priority claimed from GB9422084A external-priority patent/GB9422084D0/en
Priority claimed from GBGB9517133.6A external-priority patent/GB9517133D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CO4480099A1 publication Critical patent/CO4480099A1/en

Links

Abstract

1. UN PRE-CONCENTRADO DE MICROEMULSION QUE COM- PRENDE UN AGENTE ACTIVO DIFICILMENTE SOLUBLE, Y UN MEDIO PORTADOR, QUE COMPRENDE 1) UNA FASE HIDROFILICA LA CUAL COMPRENDE DIMETIL- ISOSORBIDE Y/O ESTER ALCANOICO DE ALQUILO INFE- RIOR,A FSE LIPOFILICA; Y 2) UNA FASE LIPOFILICA; Y 3) UN TENSOACTIVO. 2. UNA COMPOSICION DE LA REIVINDICACION 1, EN LA QUE EL AGENTE ACTIVO ES UNA CICLOSPORINA O UN MA- CROLIDO. 4. UNA COMPOSICION COMO SE REIVINDICA EN CUAL- QUIER REIVINDICACION PRECEDENTE. EN LA QUE LA FASE HIDROFILICA COMPRENDE ACETATO DE ETILO COMO EL ESTER ALCANOICO DE ALQUILO INFERIOR. 5. UNA COMPOSICION COMO SE REIVINDICA EN UNA DE LAS REIVINDICACIONES 1 A 4, PARA ADMINISTRACIN O- RAL O PARENTERAL. 6. UNA COMPOSICION FARMACEUTICA PARA ADMINISTRA- CION ENTERAL O PARENTERAL, QUE COMPRENDE UN MACRO- LIDO Y UN ACIDO. 7. UNA COMPOSICION COMO SE REIVINDICA EN LA REI- VINDICACION 6, EN LA QUE EL ACIDO ES UN ACIDO MO- NO-, DI-, O TRI-CARBOXILICO. FIGURA 11. A PRE-CONCENTRATE OF MICROEMULSION THAT INCLUDES A DIFFICULT SOLUBLE ACTIVE AGENT, AND A CARRIING MEDIUM, WHICH INCLUDES 1) A HYDROPHILIC PHASE WHICH INCLUDES DIMETHYL-ISOSORBIDE AND / OR ALCANOIC STERILE OF ALKYL INFORIORAL, FS ; AND 2) A LIPOPHILIC PHASE; AND 3) A TENSOACTIVE. 2. A COMPOSITION OF CLAIM 1, IN WHICH THE ACTIVE AGENT IS A CYCLOSPORINE OR A MOLECOLID. 4. A COMPOSITION AS CLAIMED IN ANY PRECEDING CLAIM. IN WHICH THE HYDROPHILIC PHASE INCLUDES ETHYL ACETATE AS THE LOWER ALKYL ALCANOIC ESTER. 5. A COMPOSITION AS CLAIMED IN ONE OF CLAIMS 1 TO 4, FOR ORAL OR PARENTERAL ADMINISTRATION. 6. A PHARMACEUTICAL COMPOSITION FOR ENTERAL OR PARENTERAL ADMINISTRATION, WHICH INCLUDES A MACROLID AND AN ACID. 7. A COMPOSITION AS CLAIMED IN CLAIM 6, IN WHICH THE ACID IS A MONO-, DI-, OR TRI-CARBOXYLIC ACID. FIGURE 1

CO95050316A 1994-10-26 1995-10-25 A PRE-CONCENTRATE OF MICROEMULSION THAT INCLUDES A HARDLY SOLUBLE ACTIVE AGENT AND A CARRIING MEDIA CO4480099A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421613A GB9421613D0 (en) 1994-10-26 1994-10-26 Organic compounds
GB9422084A GB9422084D0 (en) 1994-11-02 1994-11-02 Organic compounds
GBGB9517133.6A GB9517133D0 (en) 1995-08-22 1995-08-22 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CO4480099A1 true CO4480099A1 (en) 1997-07-09

Family

ID=40929712

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95050316A CO4480099A1 (en) 1994-10-26 1995-10-25 A PRE-CONCENTRATE OF MICROEMULSION THAT INCLUDES A HARDLY SOLUBLE ACTIVE AGENT AND A CARRIING MEDIA

Country Status (1)

Country Link
CO (1) CO4480099A1 (en)

Similar Documents

Publication Publication Date Title
ATE276741T1 (en) GALENIC MEDICINAL COMPOSITIONS CONTAINING FENOFIBRATE AND METHOD FOR THEIR PRODUCTION
IT1272992B (en) GALENIC FORMULATIONS CONTAINING MACROLIDES.
DK1173153T3 (en) Oral pharmaceutical preparations containing long chain triglycerides and lipophilic surfactants
KR890700036A (en) Nasal preparations and preparation methods thereof
IS4675A (en) Micrograms for use as carriers for the administration of active substances
AR015729A1 (en) A COMPOSITION IN THE FORM OF A PRECONCENTRATE IN EMULSION OR MICROEMULSION FOR ORAL ADMINISTRATION, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE AND A METHOD TO REDUCE THE VARIABILITY LEVELS OF A CYCLOSIDE OR A CYCLING.
NO20002991L (en) Pharmaceutical compositions containing an <omega> -3 fatty acid oil
CA2162993A1 (en) Solid fat nanoemulsions as drug delivery vehicles
ATE312601T1 (en) POROUS MEDICINAL MATRICES AND THEIR PRODUCTION PROCESS
KR950007859A (en) Rapamycin formulations for oral administration
LV11884A (en) High bioavailability of ciclosporina oralas
DE19581805T1 (en) Pharmaceutical compositions
ES8708185A1 (en) Microemulsion compositions.
DE69521693D1 (en) Medicinal preparations containing taxa derivatives
SV2002000969A (en) RECONSTITUABLE PARENTERAL COMPOSITION
ES2215101T3 (en) PHARMACEUTICAL FORMULATIONS CONTAINING ANTI-INFLAMMATORY ACTIVE PRODUCTS, AND THEIR EMPLOYMENT.
CO4790151A1 (en) COMPOSITIONS INCLUDING AN HIV PROTEASE INHIBITOR LIKE VX478 AND A COMPOUND OF VITAMIN E Soluble IN WATER AS VITAMIN E - TPGS
DE69611287T2 (en) FORMULATIONS OF COMPOUNDS AS NANOPARTICLES DISPERSED IN DIGESTIBLE OILS OR FATTY ACIDS
CO4480099A1 (en) A PRE-CONCENTRATE OF MICROEMULSION THAT INCLUDES A HARDLY SOLUBLE ACTIVE AGENT AND A CARRIING MEDIA
JP2006509785A (en) Oral microemulsion composition of biphenyldimethyldicarboxylic acid
CO4970788A1 (en) ORAL FORMULATIONS FOR HYDROPHILIC DRUGS
JP2006527764A (en) Nasal microemulsion containing diazepam
ATE301453T1 (en) INJECTABLE MEDICINAL FORMULATIONS OF PARTRICIN DERIVATIVES
ECSP951565A (en) PHARMACEUTICAL COMPOSITIONS
ATE212840T1 (en) SOLID MEDICINAL PREPARATIONS FOR ORAL APPLICATION WITH MODULATED RELEASE OF ACTIVE INGREDIENTS CONTAINING NICORANDIL AND METHOD FOR THE PRODUCTION THEREOF